Skip to main content

Specialist support at the point where trials lose time.

Rif Research works at study start-up: feasibility, site selection, site activation, clinical trial applications and the regulatory groundwork that determines whether a study opens on schedule or slips a quarter.

01

Complex study start-up and site activation.

Feasibility assessment, site selection governance and critical path acceleration for complex oncology, haemato-oncology, rare-disease and novel modality programmes, managing the path from protocol finalisation to first participant in.

Progressed from final protocol to first participant in within eight weeks on an accelerated COVID-19 vaccine programme.

Typical deliverables

feasibility plan, activation forecast, critical path map.

02

Regulatory readiness and submission strategy.

Clinical trial applications across the UK, Ireland and EU Member States: MHRA combined review under the reformed UK regulations, and EU CTR submission strategy via CTIS, including Part I and Part II dossier governance, substantial modifications and RFI response management. In Ireland, the HPRA and NREC-CT assess applications submitted through CTIS.

Strategic oversight of Irish EU CTR submissions through CTIS, assessed by the HPRA and NREC-CT, protecting committed start-up milestones.

Typical deliverables

submission strategy, country sequencing, document checklist, submission tracker.

03

Sponsor oversight and start-up recovery.

Independent start-up governance for sponsors managing outsourced CRO delivery. When activation timelines drift or site contracting stalls, we identify the root cause, reset the critical path and re-establish delivery momentum.

A multi-country programme recovered from severely delayed start-up timelines.

Typical deliverables

root cause review, reset critical path, recovery plan, governance framework, vendor oversight plan.

04

Quality risk management and inspection readiness.

ICH E6(R3)-aligned risk identification, vendor governance, risk registers and CAPA delivery, preparing sponsor and site teams for MHRA and European regulatory audits before issues reach the critical path.

Start-up subject matter expert through a five-day MHRA inspection, with CAPA delivery at country and study level.

Typical deliverables

risk register, escalation pathway, CAPA plan, inspection readiness review.

Discuss your study

Not sure where your timeline is slipping? We review your start-up plan, identify the bottlenecks and deliver a written recovery plan with clear owners and dates.

Ask about the diagnostic

Ways of working

start-up diagnostic, defined project, advisory retainer, interim leadership, training workshops.